Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010, 154(2):147-151 | DOI: 10.5507/bp.2010.022

HEMOLYTIC DISEASE IN THE NEWBORN – HISTORY AND PREVENTION IN THE WORLD AND THE CZECH REPUBLIC

Jiri Santavy
Department of Medical Genetics and Fetal Medicine, Faculty of Medicine, Palacky University Olomouc, Czech Republic

Background: Hemolytic disease in the newborn with its typical signs and poor prognosis has been known for centuries. Historically it can be divided into three pathological states which are fetal hydrops (hydrops fetus universalis), neonatal jaundice (icterus neonati gravis familiaris) and fetal anemia (anemia neonati). Almost 70 reports with quite accurate descriptions were found up to the end of 19th century. The patho physiological basis of the condition began to be studied at the beginning of the last century and the development of our knowledge is an example of the cooperation between pathologists, pediatricians, hematologists and later, obstetricians, immunologists and geneticists. Despite all the advances in this field it remains a serious disease up to this time. It is not managed successfully in all cases and despite successful immunological prophylaxis there are cases when we need to administer intrauterine transfusion based on the information received by dopplerometric measurement of arteria cerebri perfusion and fetal blood sampling.

Methods: Review of lover cited literature.

Conclusion: The history of the hemolytic disease in the newborn, its condition and approaches to it has not been recently compiled in the Czech Republic.

Keywords: Hemolytic disease, Newborns, History, Czech Republic

Received: February 2, 2010; Accepted: May 4, 2010; Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Santavy, J. (2010). HEMOLYTIC DISEASE IN THE NEWBORN – HISTORY AND PREVENTION IN THE WORLD AND THE CZECH REPUBLIC. Biomedical papers, 154(2), 147-151. doi: 10.5507/bp.2010.022
Download citation

References

  1. Ballanty JW. Manual of antenatal pathology and hygiene: the foetus. Green & Sons; 1902.
  2. Schriedde H. Weitere Untersuchungen über die Körnelungen der Plasmazellen. Centralbl Allg Pathol Anat 1905.
  3. Rautmann H. Über Blutbildung bei fetaler allgemeiner Wassersucht. Beitr Pathol Anat 1912.
  4. Buchan AH, Comrie JD. Four cases of congenital anemia with jaundice and enlargement of the spleen. J Path & Bact 1909. Go to original source...
  5. Gierke E. Über granulierend produktive Myokarditis mit Regeneration von Herzmuskelfasern. Beitr Pat Anat 1921.
  6. Gierke E. Über fetale Krankheiten. J Mol Med 1931. Go to original source...
  7. Diamond LK, Blackfan KP, Baty JM. Erythroblastosis fetalis and its association with universal edema of the fetus, icterus gravis. J Pediatr 1932. Go to original source...
  8. Hellman LM, Hertig AT. Erythoblastosis. Amer J Obstetr Gynecol 1938; 36:137. Go to original source...
  9. Darrow RR. Icterus gravis (erythroblastosis neonatorum, examination of etiologic considerations). Arch Pathol 1938; 25:378. Go to original source...
  10. Landsteiner K, Wiener AS. Proc Soc Exp Biol a Med 1940; 43:223.
  11. Levine P, Stetson RE. An unusual case of intragroup agglutination. J Amer Med Ass 1939; 113:126127. Go to original source...
  12. Wiener AS, Sonn EB. Genetics 1943; 28:157. Go to PubMed...
  13. Race RR, Taylor GL, Boorman KE, Dodd BE. Nature 1943; 152:563. Go to original source...
  14. Race RR, Taylor GL, Cappell DF, Mc Farlane MN. Nature 1944; 153:52. Go to original source...
  15. Boormann RE, Dodd BE. J Path & Bact 1943; 55:329. Go to original source...
  16. Cappell DF. Brit M J 1945; 400.
  17. Comrie JD. History of Medicine. University Press 1910.
  18. Hrubiško M, Hule V. Hematológia a transfúzi krvi. Obzor, Martin; 1966 a Osveta; 1970.
  19. Raška K. Serologické vyšetřování krví ve sporech o určování otcovství. Praha; 1944.
  20. Šikl K, Raška K. Fetální erythroblastosa. Nakl. Spolek českých lékařů, Praha; 1947.
  21. Ponťuch A, Války J. Possible isoimmunization following legal interruptions of pregnancy. Čs Gynek 1970; 35(6): 3578.
  22. Race RR, Sanger R. Blood groups in man. Blackwell, Oxford; 1968.
  23. Ceppellini R. Physiological genetics of human factors. Biochemistry of Human
  24. Landsteiner K, Levine P. Further observations on individua differences of human blood. Proc Soc exp Biol N. Y. 1927; 24:941942. Go to original source...
  25. Schwenzer AW, Hellman LM, Hertig AT. Das Grerinnungssystem unter der Geburt. Am J Pathol 1938.
  26. Hellman LM, Hertig AT. Pathological changes in the placenta associated with erythroblastosis of the fetus. Amer J Pathol 1938; 14, III.
  27. Polacek K, Hajek M. Haemolytic disease of the newborn control of replacement of the erythrocytes by the means of foetal haemoglobin. Rev Czech Med 1961; 7:263270.
  28. Kleinhauer K, Braun E, Betke K. Demonstation von fetalen Haemoglobin in den Erytrozyten eines Blutausstrichs. Klin Wschr 1957; 35: 637640. Go to original source... Go to PubMed...
  29. Keenan H, Pearse WH. Transplacental transmission of fetal erytrocytes. Amer J Obstet Gynecol 1963; 86:1096. Go to original source... Go to PubMed...
  30. Pfleiderer A. Die Geburtenfolge bei in Rh System sensibilisierten Frauen. Geburtsh u Frauenheilk 1965; 25:1177.
  31. Janský J. Hematologické studie u psychotiků. Sborník klinický 1907; 8:85.
  32. Moss WL. Studies in iso-agglutinins. Bull Johns Hopk Hosp 1910; 21:63.
  33. Levine P, Stetson RE. An unusual case of intragroup agglutination. J Amer Med Ass 1939; 113:126127. Go to original source...
  34. Schriedde H. Studien und Fragen zur Entzündungslehre. Gustav Fischer Verlag, 1910.
  35. Bickenbach, Martius G. Preventive examinations during pregnancy. Arztl Fortbild (Berl) 1965; 54:14965.
  36. Ponťuch A, Hrubiško M, Michalíčková J. Hemolytická choroba novorodevcov. Osveta, Martin; 1970.
  37. Finn R, Sheppard PM, Lehane D, Kulke W. Experimental studies on the prevention of Rh hemolytic disease. Brit Med J 1961; 1486:490. Go to original source...
  38. Woodrow JC at al. Prevention of Rh-Haemolytic Disease. Brit Med J 1965; 5430:279283. Go to original source... Go to PubMed...
  39. Freda VJ, Adamsons K. Exchange transfusion in utero. Amer J Obstet Gynecol 1964; 89:817. Go to original source... Go to PubMed...
  40. Schneider J, Preisler O. Die profylaxe der Thesis-sensibilisierung mit Immunoglobulin anti-D. Ärztl Forschung 1967; 21:11.
  41. Žižka Z, Calda P. Aktuální otázky sledování a léčby těžké erytrocytární aloimunizace. Mod Gyn Porod 2002; 2:241250.
  42. Liley AW. Liquor amnii analysis in the management of the pregnancy complicated by thesis sensitiation. Amer J Obstet Gynecol 1961; 82:1354. Go to original source... Go to PubMed...
  43. Queenan JT et al. Deviation in the amniotic fluid optical density at a wave lenghtof 450 nm in Rh-imunized pregnancies from 14 to 40 weeks gestation: A proposal for clinical management. Am J Obstet Gynecol 1993;168:1370. Go to original source... Go to PubMed...
  44. Procházka M, Richter J. Intrauterinní transfuze plodu při Rh inkompatibilitě. Čs Gynek 1967; 32: 119.
  45. Křikal Z, Pohanka J, Šantavý J, Látalová E. Význam amniocentézy při sledování rizikového těhotenství. Čs Gynek 1983; 48: 7, 48.
  46. Šantavý J, Křikal Z, Prášilová J, Doležal L. Prenatální diagnostika VVV ultrazvukovým přístrojem. Čs Gynek 1993; 48: 41.
  47. Šantavý J, Polák P, Župková H. Kordocentéza jako podmínka intrauterinní transfuze u Rh inkompatibility plodu. Gynekolog 1995; 4:132137.
  48. Liley AW. The use of amniocentesis and fetal transfusion in erytroblastosis fetalis. Pediatrics 1965; 35:836. Go to original source... Go to PubMed...
  49. Bowman JM, Pollock JM, Manning FA. Maternal Kell blood group alloimunization. Obstet Gynecol 1992; 79:239. Go to PubMed...
  50. Freda VJ, Adamsons K. Exchange transfusion in utero. Amer J Obstet Gynecol 1964; 89: 817. Go to original source... Go to PubMed...
  51. Preisler O, Schneider J. Versuche die Sensibilisierung rh-negativen Frauen durch antikörperhaltige Seren zu verdinen. Geburtsh u. Frauenheilk 1964; 24: 124131
  52. Valenti C. Endoamnioscopy and fetal biopsy: a new technique. Am J Obstet Gynecol 1972; 114(4): 5614. Go to original source... Go to PubMed...
  53. Hobbins JC, Mahoney MJ. In utero diagnosis of hemoglobinopathies. Technic for obtaining fetal blood. N Engl J Med 1974; 9: 290(19):10657. Go to original source... Go to PubMed...
  54. Rodeck CH, Campbell S. Umbilical-cord insertion as source of pure fetal blood for prenatal diagnosis. Lancet 1979; 9,1(8128):12445. Go to original source...
  55. Antsaklis AI, Papantoniou NE, Mesogitis SA et al. Cardiocentesis: an alternative method of fetal blood sampling for prenatal diagnosis of hemoglobinopathies. Obstet Gynecol 1992; 79:633630.
  56. Bang J, Bock JE, Trolle D. Ultrasound-guided fetal intravenous transfusion for severe rhesus haemolytic disease. Br Med J 1982; (Clin Res Ed) 6: 284(6313): 373374. Go to original source... Go to PubMed...
  57. Daffos F, Capella-Pavlovsky M, Forestier F. Am J Obstet Gynecol 1983; 15; 146(8): 9857. Go to PubMed...
  58. Calda P, Žižka Z, Zlatohlávková B et al. Diagnostika a léčba erytrocytární alloimunizace v těhotenství. Čs Gynek 1998; 63:170 174.
  59. Genetics. Churchill, London; 1959;242261.
  60. Mari G. and the Collaborative Group for Doppler Assesment of the Blood Velocity in Anemic Fetuses. Noninvasive diagnossis by Doppler Ultrasonography of fetal anemie due to maternalred cell alloimunisation. N Eng J Med 2000; 9:342. Go to original source...
  61. Zimmerman R, Carpenter RJ, Durig P et al. Longitudinal measurement of peak systolic velocity the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimunisation: a prospective multicentre trial. Brit J Obstet Gynecol 2002; 109:746752. Go to original source... Go to PubMed...
  62. Ľubušký M, Procházka M, Šantavý J, Machač Š, Míčková I. Dopplerometrie při posouzení fetální anémie. Čs Gynek 2004; 69(4):316320.